Galectin Therapeutics Announces Pricing of $9.8 Million Registered Direct Offering

Go back to Galectin Therapeutics Announces Pricing of $9.8 Million Registered Direct Offering
GALECTIN (NASDAQ: GALT) Delayed: 3.93 -0.09 (2.24%)
Previous Close $4.02    52 Week High $3.05 
Open $4.02    52 Week Low $0.49 
Day High $4.05    P/E N/A 
Day Low $3.92    EPS $-1.32 
Volume 43,465